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1. Introduction
The range of functions ascribed to neutrophils has expanded
signiﬁcantly, from terminally differentiated, short-lived phago-
cytes that are solely involved in innate immune responses to cells
that are now believed to inﬂuence the development of adaptive
immune responses. Emerging evidence indicates that neutrophils
may communicate with T cells through direct cell contact via
major histocompatibility complex (MHC) Class I, Class II [1,2], and
co-stimulatory molecules [3,4]. Additionally, a neutrophil-derived
cytokine milieu [5] may have signiﬁcant impact on the adaptive
response to infection, for example via neutrophil-derived IL-12
[6,7].
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Open access under CC BY license.cribed as short lived, terminally differentiated phagocytes that contribute
onse. Recent evidence of neutrophil cytokine production and expression of
has suggested that neutrophils are likely to inﬂuence adaptive responses
antigen presenting cells. Under certain inﬂammatory conditions human
ocompatibilty complex (MHC) Class II and the costimulatory molecules
oyed a murine T cell hybridoma with a transgenic T cell receptor speciﬁc
(OVA323–339), and a green ﬂuorescent reporter of T cell receptor ligation,
il-T cell interactions. These cells provide an ideal model system, allowing
n speciﬁcity and a clear readout of T cell activation. Additionally, whilst
ously been shown to stimulate MHC Class I-dependent CD8+ T cell acti-
n via MHC Class II-expressing neutrophils has not been investigated. We
rine neutrophils, loading with OVA323–339 and co-culturing with T cells
Class II complex, and this resulted in T cell activation, as determined by
cent protein reporter. Antigen-pulsed neutrophils were also able to prime
in a contact-dependent manner, as shown by proliferation and cytokine
ocyteswas not due to contaminatingmacrophages. These studies demon-
present MHC Class II-restricted peptides and induce T cell proliferation,
neutrophils, and demonstrate a novel pro inﬂammatory effect of murine
© 2008 Elsevier B.V.
There is considerable evidence to suggest that neutrophils sat-
Open access under CC BY licenseisfy the criteria of antigen presenting cells, with some capacity to
process antigen. Human neutrophils express MHC Class II, either
following in vitro activation via CD11b [8,9], with IFN, and GM-
CSF [10,11] or following in vivo activation in RA synovial ﬂuid [4,12],
in patients with active Wegener’s Granulomatosis [13], in patients
receiving GM-CSF [14], and in persistent localized Staphylococcus
aureus infections [15]. In addition to MHC Class II expression, stim-
ulation of normal human PMN with IFN, or via CD11b induces
CD80 and CD86 expression [8,11]. Human neutrophil presentation
of superantigens is documented [2]. However, there are conﬂict-
ing reports of neutrophils’ capacity to process and present tetanus
toxoid on MHC Class II and activate T cells [1,2]. A capacity for
extracellular antigen processing had been suggested as neutrophil
gelatinasemay cleave collagen to a Class II restricted immunodom-
inant epitope [16].
Harding et al. demonstrated murine neutrophil Class I
restricted antigen presentation [17] and additionally show that
neutrophils processed phagocytosed bacteria via an alternate
MHC Class I antigen-processing pathway, and such neutrophils
may ‘regurgitate’ processed peptide into the extracellular space
and this peptide may then bind MHC Class I on neighbour-
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ing cells (e.g. macrophages) for presentation to CD8 cells
[17].
Human studies of antigen-speciﬁc neutrophil-T cell interactions
are confounded by low frequency of antigen-speciﬁc T cells in
peripheral blood, variation of MHC allele expression, which there-
fore impedes ideal peptide antigen identiﬁcation. To overcome
these complications, we have employed a murine model system.
Moreover, despite the important role of theneutrophil in thepatho-
genesis of numerous inﬂammatory diseases, many of which are
modelled in rodents, there is a relative paucity of information
on murine Class II restricted antigen presentation. We, therefore,
sought to investigatewhethermurine neutrophils present antigens
via MHC Class II.
2. Materials and methods
2.1. Murine peritoneal neutrophil and macrophage separation
Peritoneal exudate cells (PEC) were obtained as previously
described [18]. Brieﬂy, 6–8-week-old BALB/c mice (Harlan Olac,
Bicester, UK) received 1.5ml i.p. Brewers thioglycollate medium
(Difco, East Molesey, UK) and 4h later animals were sacriﬁced and
cells harvested by peritoneal lavage. PEC were washed once then
resuspended in 8ml PBS, and layered over 3ml Histopaque® 1083
(Sigma, Poole, UK), then centrifuged at 700× g for 30min at 20 ◦C.
The enriched population of neutrophils contained within the cell
pellet was washed twice in RPMI (Invitrogen, Paisley, UK) then
resuspended at 2×106 ml−1 in medium supplemented with 2mM
l-glutamine, 100 IU penicillin, 100g/ml streptomycin (all Invit-
rogen) and 10% foetal calf serum (Harlan). Peritoneal macrophages
were obtained by adhering PEC to a polystyrene ﬂask for 3–4h after
which remaining adherent cells were incubated with ice cold PBS
(without calcium or magnesium) at 4 ◦C for 10min. Cells were har-
vested with a cell scraper, then washed in RPMI and resuspended
at 2×106 ml−1.
2.2. Murine lymph node preparation
DO11.10mice, with CD4+ T cells speciﬁc for the OVA323–339 pep-
tide in the context of the MHC Class II molecule I-Ad [19] were
obtained originally from N. Lycke, University of Go¨teborg, Sweden.
This T cell receptor is recognized by the KJ1.26 clonotypic anti-
body. Single cell suspensions of lymph nodes from DO11.10 mice
were obtained by passing tissues through 100m Nitex mem-
brane (Cadish, London, UK) using a 5ml syringe plunger. To enrich
for lymphocytes in lymph node cell suspensions, cells were resus-
pended at 4×106 ml−1 in complete RPMI, and cultured in 150 cm3
polystyrene ﬂasks (Iwaki, Japan), for 2h after which non-adherent
cells were removed. Cells were washed three times in RPMI and
resuspended at the desired cell concentration in complete RPMI
with 25mM HEPES.
2.3. Assessment of cell proliferation and cytokine production
Cellswere culturedunder conditions indicated inﬁgure legends.
Where indicated, transwells (0.2m membrane, Fisher Scientiﬁc,
UK) separated cell populations. Cell proliferation was assessed
by incorporation of [3H]thymidine (0.5Ci/well) for the last 18h
of culture. Cells were harvested using a Betaplate 96-well har-
vester (WallacOy, Turku, Finland) and [3H]thymidine incorporation
measured on a Betaplate liquid scintillation counter (Wallac).
Concentration of cytokines in supernatants were estimated by
ELISA. Paired antibodies (Pharmingen, Oxford, UK) were used in
accordance with the manufacturer’s recommendations. All assays
were optimised and validated prior to use. Maxisorp 96-wellLetters 118 (2008) 49–54
plates (Nunc) were coated with capture antibody in 0.1M NaHCO3
overnight at 4 ◦C. Plates were blocked for 2h; samples and stan-
dards added for 2h, followed by biotinylated secondary antibody
for 1h, then ExtrAvidin peroxidase (Sigma) conjugate for 45min.
Plates were developed with TMB (3,3′,5,5′-tetra-methylbenzidine,
KPL, Gaithersburg, USA), and then read at 630nm with a Dynex
MRX II plate reader and analysed using Dynex Revelation 3.2 soft-
ware (Dynex,Middlesex,UK). The levels of cytokine in supernatants
were calculated by comparison with recombinant cytokine stan-
dards (R&D Systems, Abingdon, UK).
2.4. Hybridoma cells
The DO11.10-GFP hybridoma (kind gift of David Underhill,
Department of Immunology, University of Washington, Seattle,
Washington [20]) cells were grown in medium containing a
0.5mg/ml geneticin. Co-cultures were established in which neu-
trophils ormacrophageswere incubatedwith 10g/ml OVA323–339
peptide and DO11.10-GFP hybridoma cells, in the ratio indicated in
the ﬁgure legends. Cells were cultured for 14h, washed, and then
analysed by ﬂow cytometry.
2.5. Flow cytometry
Aliquots of 1×106 cells in 12mm×75mm polystyrene tubes
(Falcon BD, Oxford, UK) were resuspended in 100l FACS buffer
(PBS, 2% FCS and 0.05% NaN3) containing Fc Block (Becton Dick-
enson, Oxford, UK) as well as appropriate antibody or isotype
control. Neutrophils were identiﬁed with anti GR-1 (RB6-8C5, Cal-
tag), macrophages with anti F4/80 (C1:A3-1, Caltag), and MHC
Class II assessed (2G9, BD Biosciences), and T cells identiﬁed using
anti CD4+ (RM4-5, BD) and a clonotypic antibody speciﬁc for the
OVA323–339 TCR (KJ1.26). After washing, samples were analyzed
using a FACSCalibur ﬂow cytometer equipped with a 488nm argon
laser and a 635nm red diode laser and analyzed using CellQuest
software (both BD).
2.6. Statistical analysis
Statistical analysis was performed on data as indicated in the
ﬁgure legends, using Minitab software.
3. Results3.1. Puriﬁcation of murine neutrophils
Neutrophils were puriﬁed from thioglycollate-induced peri-
toneal exudate cells (PEC), as there is a relative paucity of
neutrophils in murine peripheral blood (data not shown). PEC
were harvested 4h post-thioglycollate administration, previously
shown to be the peak of neutrophil recruitment, and afterwhich an
increasing proportion of macrophages are recruited [18]. Approx-
imately 65% of thioglycollate-induced PEC were identiﬁed as
neutrophils on the basis of GR1 staining (data not shown). PECwere
further enhanced for neutrophils with a Ficoll gradient puriﬁca-
tion as previously described [18]. Following puriﬁcation, samples
were routinely 85% GR1 positive (Fig. 1a). Importantly, samples
contained few macrophages (<4%) as determined by F4/80 stain-
ing (Fig. 1b). Cytospins of neutrophil preparations were prepared
and demonstrated characteristic multilobed nuclei in >85% or cells
(data not shown). Macrophage samples were 50–60% F4/80 posi-
tive cells (data not shown). Murine neutrophils, expressing GR-1,
were found to express MHC Class II (Fig. 1c), albeit at low levels
relative to F4/80 positive macrophages (Fig. 1d).
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positive neutrophils showed low levels of MHC Class II expression (c); F4/80 positive m
representative of three independent experiments.
3.2. Murine neutrophils are able to present peptide antigen
The murine T cell hybridoma, DO11.10-GFP, is activated by
OVA323–339 peptide in the context of I-Ad, without any requirement
for co-stimulation. The hybridoma does not respond to peptide
Fig. 2. GFP expression by the DO11.10-GFP hybridoma following co-culture with
APCs. Puriﬁedmurine neutrophils (PMN) ormacrophages (Mac) were culturedwith
10g/ml OVA323–339 peptide and DO11.10-GFP cells for 14h. Cells were washed
and GFP expression was assessed by ﬂow cytometry. ‘Background’ is a measure
of GFP expression of DO11.10-GFP cells cultured with OVA323–339 alone; anti-CD3
was used as a positive control. Data are mean± S.E.M. of three experiments. In each
experiment, neutrophilswerepuriﬁed from thioglycollate-inducedPECpooled from
5BALB/cmice. Macrophageswere obtained from two similarly treated BALB/cmice.
*p<0.05 vs. background by Mann–Whitney U test.were greater than 85% GR1 positive (a), and less than 4% F4/80 positive (b). GR-1
acrophages showed relatively higher MHC Class II expression (d). Data shown are
alone (Fig. 2, ‘background’). Neutrophils or macrophages alone had
no effect on GFP expression by DO11.10-GFP. However, neutrophils
ormacrophages loadedwith OVA323–339 stimulated signiﬁcant GFP
expression by hybridoma cells when cultured at a 1:1 ratio. A dilu-
tion of macrophages was performed to estimate the contribution
of contaminating macrophages to the results observed with neu-
trophil populations, demonstrating that at a ratio of 1 macrophage
to 10 DO11.10-GFP cells, there was signiﬁcantly less expression of
GFP protein compared to that induced by neutrophils at a 1:1 ratio
(Fig. 2). At a ratio of 1:100, there was no consistent GFP expres-
sion detected (data not shown). As there were <5% F4/80 positive
macrophages contaminating the neutrophil samples, these titra-
tion experiments indicated that only a small proportion of the T
cell hybridoma activation observed in the ‘neutrophil presentation’
assays could be attributable to macrophage contamination.
3.3. Neutrophils can drive na¨ıve T cell proliferation and cytokine
production
To investigate neutrophils antigen presentation in a co-
stimulation dependent system, and the ability of neutrophils not
only to present but also to prime T cells, neutrophils were co-
cultured with primary T cells. Lymph nodes were obtained from
DO11.10 transgenic BALB/c mice. Single cell suspensions of lymph
nodes were allowed to adhere to plastic for 3h to remove the
majority of adherent antigen presenting cells, after which the pop-
ulation was routinely 70% CD3 positive (data not shown). The
presence of remaining endogenous APCs in the lymph node facil-
itated a strong response to OVA323–339 peptide alone (Fig. 3a, c
and e). Therefore, neutrophils and macrophages were pulsed with
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were obtained as in Fig. 2. Cells were cultured for 72h and proliferation was assessed by [
assessed by ELISA of cell culture supernatants. DO11.10 lymph node cells were either cult
macrophages (b, d, and f). The ratio of APC to T cell in the culture, and whether the APC
x-axis. Data are mean± S.E.M. of triplicate cultures. *p<0.05 vs. medium by Student’s t-te
OVA323–339 for 2h then washed three times to remove unbound
peptide prior to the addition of transgenic T cells. Cells were
co-cultured for 72h at the ratios indicated in the ﬁgure leg-
ends. Neutrophils pulsed with OVA323–339-induced proliferation
(Fig. 3b), IL-2 (Fig. 3d) and IFN (Fig. 3f) production. Low lev-
Fig. 4. Antigen-speciﬁc proliferation and cytokine production was cell contact
dependent. Single cell suspensions derived from lymphnodes of DO11.10mice,were
stimulated with Con A, OVA323–339, or APCs (DCs or neutrophils), which had been
pulsed with OVA323–339. In parallel cultures, the stimulus was separated from the
responding T cells by a transwell membrane. The stimuli were placed in the upper
compartment, and (a) proliferation and (b) IFN production by the OVA323–339-
speciﬁc T cells in the lower chamber was assessed. T cells did not respond when
cultured with APCs alone (data not shown). Similarly, culturing T cells in the upper
chambers resulted in no measurable response in the lower chambers. Data are
mean± S.E.M. of triplicate cultures and representative of two similar experiments.odeswere obtained from aDO11.10 transgenicmouse; neutrophils ormacrophages
3H] thymidine incorporation over the ﬁnal 18h of culture; cytokine production was
ured only with the stimuli indicated (a, c and e), or co-cultured with neutrophils or
was pulsed with OVA323–339 prior to addition to the co-culture, is indicated on the
st, representative of three similar experiments.
els of IL-5 were detected in some experiments (data not shown).
The neutrophil-induced responses were less than those evoked by
macrophages at the same cell ratio. A titration of macrophages was
performed to give an estimate of the contribution of contaminating
cells, demonstrating that only a small proportion of neutrophil-
induced T cell responses could be attributable to contaminating
macrophages.
3.4. Cell contact dependence of neutrophil T cell interactions
To determine the relative contribution of cell contact dependent
mechanisms and soluble factors in neutrophil-T cell interactions,
cells were separated by 0.2m membranes placed between the
cell populations, allowing diffusion of soluble proteins but pre-
venting cell contact. The responding OVA323–339-speciﬁc T cells
were not a 100% pure T cell population and contained some
APCs, demonstrated by the lymph node response to OVA323–339
alone (Fig. 4a and b ‘OVA’). Thus, the transwells permitted inves-
tigation of whether lymph node-derived APCs were presenting
soluble proteins derived from dead or degraded neutrophils.
Bone marrow-derived dendritic cells (DC) were used as a pos-
itive control. Free OVA323–339 or ConA crossed the transwell
membrane and stimulated cell proliferation and cytokine pro-
duction (Fig. 4a). However, when antigen pulsed neutrophils
were separated from the lymph node cells by the transwell,
antigen-speciﬁcproliferationandcytokineproductionwas reduced
(Fig. 4a and b). Importantly, antigen pulsed cell cultures did
not release sufﬁcient free antigen to stimulate a response
from the OVA323–339-speciﬁc T cells below (Fig. 4a). Thus, the
antigen-speciﬁc T cell proliferation and cytokine production
induced by neutrophil antigen presentation is cell contact depen-
dent.
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4. Discussion
Data presented here demonstrate that murine neutrophils are
indeed capable of directly presenting antigen on Class II MHC and
activating T cells independently of other APCs. The DO11.10-GFP
hybridoma cells respond exclusively in a Class II restrictedmanner,
and our data demonstrate that neutrophils, rather than contami-
nating cells, were mediating this response.
At comparable cell ratios, neutrophil-mediated T cell activation
was lower than that mediated by macrophages, commensu-
rate with reduced expression of MHC Class II by neutrophils.
Althoughneutrophils havebeen reported to express co-stimulatory
molecules, we detected only low levels of CD40 and were unable
to consistently detect CD80 or CD86 in our neutrophil prepa-
rations (in contrast to the F4/80 positive macrophages which
expressed CD40, CD80 and CD86; data not shown). Thus it is pos-
sible that: co-stimulatory molecule expression below the limits
of detection of methods used here is sufﬁcient for inducing a
response, that T cells are responding in a co-stimulation indepen-
dent manner, or that co-stimulation has occurred via alternative
molecules.
Neutrophil antigen processing capacity was investigated using
whole ovalbumin protein compared to OVA323–339. These studies
indicated that these neutrophils did not process the ovalbumin
effectively, demonstrated by a lack of response by DO11.10-GFP
hybridoma (data not shown). An MHC Class I processing pathway
within neutrophils was elegantly deﬁnedwith E. coli transfected to
express aMHC Class I restricted epitope of OVA. This demonstrated
that neutrophils are capable of non-classical antigen processing
for presentation on MHC Class I [17]. Although neutrophil enzyme
mediated degradation of collagen generates a Class II epitopes
(14), there is no current evidence of any Class II processing path-
way. It has been proposed that as macrophage phagosomes are
adequate for Class II antigen processing [21], therefore a paral-
lel system may exist in neutrophils. A deﬁnitive investigation of
murine neutrophil MHC Class II antigen processing awaits trans-
fection of bacteria with OVA323–339, thus elucidating the effects on
antigen processing of concomitant neutrophil activation by bacte-
ria.
There is increasing evidence documenting the potential for
neutrophils to acquiremacrophage [22] or dendritic cell (3) charac-
teristics, often in response to in vitro conditions. We document in
vitro antigen presentation by in vivo activated neutrophils. It will
be of interest to delineate whether such neutrophil behaviour can
be observed strictly in vivo. Physiologically, the location of such
neutrophil-T cell interactions is likely to be restricted to sites of
chronic or established inﬂammation, for example persistent bacte-
rial infection [15].Neutrophilshavebeenshowntodegradeproteins
to release antigens recognized by auto reactive T cells [16], and
such antigens may then be transported to the draining LN by
migrating DCs. Due to the neutrophils’ unique proteolytic activi-
ties, this may represent a mechanism of presentation of novel or
cryptic antigens. Furthermore, there is evidence that neutrophils
may passively acquire membrane proteins, including MHC, from
other cells [23]. In our GFP-hybridoma studies (Fig. 2), this seems
unlikely as the neutrophils were harvested from the peritoneum
before there was signiﬁcant in vivo macrophage migration, and
immediately puriﬁed in vitro. However, this phenomenon may
have contributed to the neutrophil mediated T cell activation in
co-culture (Fig. 3).
There are overall fewer studies ofmurine neutrophils compared
to humanneutrophils,which is likely to be a reﬂection of the ease of
acquiring human neutrophils that constitute 70% of circulating leu-
cocytes, compared to limited quantity of murine peripheral blood
available and the relative paucity of neutrophils, contributing only
[
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20% of circulating leukocytes in rodents. These studies were only
possible through use of rodent cells, as the TCR transgenic T cells
absolutely control antigen speciﬁcity of response, which was cen-
tral to this investigation of neutrophil-T cell interactions. However,
the signiﬁcantly different proportion of neutrophils in murine and
human peripheral blood raises questions as towhethermurine and
human neutrophils perform parallel functions as is assumed. Our
data document a novel, Class II restricted antigen presenting func-
tion of murine neutrophils, conﬁrming ﬁndings in other human
systems, and expanding our understanding of the role of the neu-
trophil in the adaptive immune response.
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